Quantitative Analysis of Four Long-Chain Lysophosphatidylcholines (LPCs) in Dried Blood Spot using Liquid Chromatography Tandem Mass Spectrometry for Clinical Research

Importance of LPC Analysis in Dried Blood Spots

Quantification of long-chain lysophosphatidylcholines (LPCs) in dried blood spots (DBS) provides a minimally invasive approach to monitor lipid metabolism and disease biomarkers in clinical research. This method can facilitate large-scale population studies, newborn screening, and longitudinal monitoring in metabolic disorders.

Objectives and Study Overview

The primary goal was to develop and validate a rapid, reliable ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method for four saturated long-chain LPCs (C20:0, C22:0, C24:0 and C26:0) in DBS. Method performance was assessed for linearity, precision, accuracy, carryover, matrix effects and selectivity.

Used Instrumentation

• ACQUITY UPLC I-Class PLUS FL System
• Xevo TQ-S micro Triple Quadrupole Mass Spectrometer
• ACQUITY Premier CSH C18 Column (2.1 × 50 mm, 1.7 µm)
• Waters 96-well Sample Collection Plate
• MassLynx v4.2 and TargetLynx XS v4.2 software

Methodology

Samples were prepared by punching 3.2 mm spots from DBS cards and extracting with methanol containing deuterated internal standards. Extraction was performed at 500 rpm for 30 minutes at room temperature. Chromatographic separation was achieved at 55 °C using a gradient of ammonium acetate-buffered acetonitrile/water and isopropanol/acetonitrile. Negative electrospray ionization generated acetate adduct precursor ions monitored by multiple reaction monitoring (MRM) for each LPC.

Results and Discussion

The method demonstrated:

• Linearity over 0.1–10 µmol/L (r2 ≥ 0.99)
• Limit of quantification with acceptable bias and precision (≤ 15% CV and ≤ 20% bias)
• No significant carryover after 2 µmol/L injections
• Minimal matrix effects confirmed by post-column infusion
• Baseline chromatographic resolution of isobaric interferences

Lower limit of minor interest (LLMI) values ranged between 0.16 and 0.27 µmol/L for the four LPCs. Total run time was 6.3 minutes, enabling analysis of ~220 samples per 24 h.

Benefits and Practical Applications

This method offers:

• Simple sample preparation requiring only methanol extraction
• High throughput with a 7-minute injection-to-injection cycle
• Robust quantification with high specificity in negative ESI mode
• Reliable detection of long-chain LPCs in clinical research settings

Future Trends and Opportunities

Advances may include automated DBS processing, expansion to additional lipid biomarkers, integration with dried plasma spot analysis, and coupling with high-resolution MS for broader lipid profiling. Emerging miniaturized platforms and digital microfluidics could further streamline lipid quantitation workflows.

Conclusion

A validated UHPLC-MS/MS method for four long-chain LPCs in DBS demonstrates excellent linearity, precision, and selectivity. Its rapid sample preparation, minimal carryover and strong robustness make it well suited for high-throughput clinical research applications.